10:30 AM - 12:00 PM Saturday, January 19

Plenary Session IV - The Opioid Epidemic and Neuromodulation: Understanding its Role in Treatment

The opioid crisis in the United States has brought about the rapid need for understanding the optimal role and the advancement of non-opioid forms of pain control. This session will highlight the current challenges surrounding opioids and the role that neuromodulation and innovative technologies may have in providing successful treatment strategies.

Read more...
1:30 PM - 3:00 PM Saturday, January 19

Intrathecal Therapy: Current and Future Best Practice

Intrathecal therapy is a durable, safe, and effective strategy to serve the cancer and non-cancer chronic pain population. This session will provide an overview of best practices regarding implementation of the therapy, risk-mitigating strategies, durable treatment options, and management strategies. Future innovations of Intrathecal therapy will also be discussed.

Read more...
1:30 PM - 3:00 PM Saturday, January 19

Role of Neuromodulation in Addiction and Affective Disorders

This session will focus on the potential role of neuromodulation to treat addiction and affective disorders. Speakers will present current knowledge of the neural anatomy relevant to these disorders and neuromodulation. Both non-invasive and invasive neuromodulation approaches will be presented along with methods to develop advanced neuromodulation strategies that exploit knowledge of the underlying neural circuity.

Read more...
Venue:
Caesars Palace
Speaker:

Scott F. Lempka, PhD

Damian S. Shin, MSc, PhD

1:30 PM - 3:00 PM Saturday, January 19

Multidisciplinary Pain Care to Optimize Neuromodulation Outcomes for Pain

Patients with long term chronic pain who benefit from neuromodulation often have residual pain, rehabilitation, and mental health co-morbidities that remain after successful neuromodulation implementation. Such patients can realize additional improvement by treating and attending to these co-morbidities. This session will focus on the latest medical, mental health, and regenerative medicine approaches to help optimize neuromodulation outcomes.

Read more...
Venue:
Caesars Palace
Speaker:

Tim J. Lamer, MD

W Michael Hooten, MD

1:30 PM - 3:00 PM Saturday, January 19

Neuromodulation and Function: Optimizing Outcomes: Time to Pay Attention to the Pre- and Post-Operative Period

Though the objective of neuromodulation is often symptomatic improvement (e.g., analgesic benefit, reduction of tremors and spasticity) the outcome that really matters in the long-run is the restoration of functional ability. This goal has not yet received the attention that it deserves either in research or in clinical practice. However, recent advances in measuring and treating disability and strategies to reduce it provide us with an opportunity to reach for the “Holy Grail” of improving function in patients with pain, paresis or spasticity or any combination of these syndromes. This session will offer an opportunity for attendees to learn about some of the important advances in these areas.

Read more...
Subscribe to this RSS feed

Faculty subject to change.